| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2018-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c40734012fb74cd0ecc40d0cd1dbfe74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610edfcb2af5a9387eef60ae99ecd645
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aca8608f674231321a720fd19518a807
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca114bceb2e32972e962c6c591353fd7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6219ccf981abd1977ac6c29e6b000d84 |
| publicationDate |
2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020008127-A2 |
| titleOfInvention |
antibodies and antibody-drug conjugates specific for cd123 and their uses |
| abstract |
the present invention provides antibodies that specifically bind to cd123. the present invention further relates to immunoconjugates (for example, antibody-drug conjugates or adcs) which comprise such antibodies, nucleic acids encoding the antibody and methods of obtaining such antibodies. the invention further relates to therapeutic methods for using these antibodies and adcs for the treatment of a condition associated with cells that express cd123 (e.g., cancer or autoimmune disease). |
| priorityDate |
2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |